What is the treatment for sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Sinusitis

For acute bacterial sinusitis in adults, start with amoxicillin-clavulanate 875/125 mg twice daily for 5-10 days as first-line therapy, reserving fluoroquinolones like levofloxacin for treatment failures or complicated disease. 1, 2

Confirming the Diagnosis Before Treatment

Before initiating antibiotics, confirm acute bacterial sinusitis using one of three clinical patterns 2:

  • Persistent symptoms ≥10 days without improvement (nasal discharge, congestion, facial pain/pressure)
  • Severe symptoms for ≥3 consecutive days (fever >39°C, purulent discharge, severe facial pain)
  • "Double sickening" - worsening after initial improvement from a viral upper respiratory infection

Most acute rhinosinusitis is viral and resolves within 7 days without antibiotics 2. Imaging is not routinely required but may enhance diagnostic certainty in adults when the clinical picture is unclear 2.

First-Line Antibiotic Treatment

Standard Approach for Uncomplicated Disease

Amoxicillin-clavulanate 875/125 mg twice daily for 5-10 days is the preferred first-line agent 1, 2. This provides coverage against β-lactamase-producing H. influenzae and M. catarrhalis, which have become increasingly prevalent 2.

  • Plain amoxicillin 500 mg twice daily remains acceptable for mild disease without recent antibiotic exposure 1
  • For moderate disease, use amoxicillin 875 mg twice daily 1
  • Treatment duration of 5-7 days has comparable efficacy to 10-14 days with fewer side effects 1
  • Continue treatment until symptom-free for 7 days (typically 10-14 days total) 1, 2

High-Dose Regimens for Resistant Organisms

For regions with high bacterial resistance, recent antibiotic use, or more severe cases, use high-dose amoxicillin-clavulanate 1:

  • Adults: 2000 mg amoxicillin with 125 mg clavulanate twice daily 1
  • Pediatrics: 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 2

Important caveat: Recent research shows high-dose formulations may increase severe diarrhea (15.8% vs 4.8%) without consistently superior efficacy compared to standard dosing 3. The immediate-release high-dose formulation showed an 18% improvement rate at day 3, but the extended-release formulation showed no benefit 3.

Treatment for Penicillin-Allergic Patients

For documented penicillin allergy, the risk of cross-reactivity with second- and third-generation cephalosporins is negligible 1, 2:

  • Second-generation cephalosporins: Cefuroxime axetil 1, 2
  • Third-generation cephalosporins: Cefpodoxime proxetil or cefdinir (superior activity against H. influenzae) 1, 2

Critical pitfall: Azithromycin and other macrolides should NOT be used due to 20-25% resistance rates among S. pneumoniae and H. influenzae 1, 2. French and American guidelines explicitly exclude macrolides from recommended therapy 2.

For severe beta-lactam allergy where cephalosporins are contraindicated, doxycycline 100 mg once daily for 10 days is an option, though it has limited activity against H. influenzae and a 20-25% predicted bacteriologic failure rate 2.

Second-Line Treatment for Failure

If no improvement occurs after 3-5 days of initial therapy, switch to respiratory fluoroquinolones 1, 2:

  • Levofloxacin 500-750 mg once daily for 5-10 days 1, 4
  • Moxifloxacin is an alternative 1, 2

Fluoroquinolones provide 90-92% predicted clinical efficacy and excellent coverage against multi-drug resistant S. pneumoniae (MDRSP) 1, 2. The FDA label confirms levofloxacin's effectiveness for MDRSP with 95% clinical and bacteriologic success 4.

Reserve fluoroquinolones specifically for 1, 2:

  • Treatment failures after 3-5 days
  • Frontal, ethmoidal, or sphenoidal sinusitis (higher complication risk)
  • Multi-drug resistant organisms
  • Severe disease requiring hospitalization

Do not use fluoroquinolones as routine first-line therapy to prevent resistance development 1, 2.

Treatment Based on Anatomic Location

Maxillary Sinusitis (Most Common)

  • Use standard first-line antibiotics (amoxicillin-clavulanate) 1, 2
  • Symptoms: unilateral/bilateral infraorbital pain worsening when bending forward, pulsatile, peaking evening/night 2

Frontal, Ethmoidal, or Sphenoidal Sinusitis

  • Consider fluoroquinolones (levofloxacin or moxifloxacin) due to higher risk of serious complications 1, 2
  • These locations require more aggressive treatment 1

Adjunctive Therapies

Intranasal Corticosteroids

  • Recommended as adjunct to antibiotics in both acute and chronic sinusitis 1, 2
  • Particularly helpful with marked mucosal edema 1
  • May decrease need for antibiotics 2

Oral Corticosteroids

  • Consider short-term use (typically 5 days) for patients with 2:
    • Marked mucosal edema
    • Failure to respond to initial antibiotic treatment
    • Nasal polyposis
    • Acute hyperalgic sinusitis (severe pain)

Dexamethasone 4 mg may be used as short-term adjunctive therapy but should never be used as monotherapy for bacterial sinusitis 2.

Symptomatic Treatments

  • Analgesics (acetaminophen, NSAIDs) for pain 2
  • Saline nasal irrigation for symptomatic relief 2
  • Decongestants (systemic or topical) as needed, though evidence is limited 1, 2
  • Adequate hydration, warm facial packs, sleeping with head elevated 2

Pediatric Considerations

Standard Dosing

  • Amoxicillin 45 mg/kg/day in 2 divided doses for mild disease 2
  • High-dose amoxicillin 80-90 mg/kg/day in 2 divided doses for areas with high prevalence of resistant S. pneumoniae or risk factors (age <2 years, daycare attendance, recent antibiotic use) 2

Penicillin-Allergic Children

  • Cefpodoxime proxetil 8 mg/kg/day in two doses 2
  • Ceftriaxone 50 mg/kg as single dose for children unable to tolerate oral medication 2

Treatment Duration

  • Same as adults: 10-14 days until symptom-free for 7 days 2
  • Reassess at 72 hours if no improvement 2

Doxycycline is contraindicated in children <8 years old due to risk of tooth enamel discoloration 2.

Watchful Waiting Option

For adults with uncomplicated acute bacterial sinusitis, watchful waiting without immediate antibiotics is appropriate when follow-up can be assured 1:

  • Start antibiotics if no improvement by 7 days or worsening at any time 1
  • The number needed to treat with antibiotics is 3-5 for persistent symptoms 2
  • This approach reduces unnecessary antibiotic exposure while maintaining safety 1

When to Escalate Care

Immediate Hospitalization Required

  • Orbital involvement (periorbital cellulitis, vision changes) 1
  • Neurological symptoms (severe headache, altered mental status, meningeal signs) 1
  • These complications require parenteral antibiotics 1

Specialist Referral Indicated

  • Symptoms persist after 21-28 days of antibiotic treatment 1
  • Recurrent sinusitis (≥3 episodes per year) 2
  • Need to clarify allergic or immunologic basis 2
  • Sinusitis associated with unusual opportunistic infections 2

When referring for treatment failure, consider broader-spectrum antibiotics, anaerobic coverage, and CT imaging 1.

Critical Pitfalls to Avoid

  • Do not use azithromycin - 20-25% resistance rates make it unsuitable for acute bacterial sinusitis 1, 2
  • Complete the full antibiotic course even after symptoms improve to prevent relapse 2
  • Reassess at 3-5 days if no improvement to avoid prolonged treatment failure 1, 2
  • Reserve fluoroquinolones for second-line therapy only to prevent resistance 1, 2
  • Ensure adequate treatment duration - minimum 5 days, typically 7-10 days, or until symptom-free for 7 days 1, 2
  • Evaluate for underlying conditions in recurrent cases (allergies, immunodeficiency, anatomical abnormalities) 1, 2

References

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.